There’s no way around it: Where you open an IRA matters to your investment portfolio, and it affects more than the price you pay. Brokers offer different investment menus, research capabilities, and tools to help you plan for retirement. Today we’re taking a look at how Capital One and Merrill Edge compare on key criteria for retirement investors.
Commission prices
Capital One and Merrill Edge offer the exact same pricing at their standard rates.
Brokerage
Stocks and ETFs
Stock Options
Mutual Funds
Merrill Edge
$6.95 per trade
$6.95 + $0.75 per contract
$19.95 per purchase
Capital One
$6.95 per trade
$6.95 + $0.75 per contract
stock market online: Comp En De Mn Cemig ADS(CIG)
Advisors’ Opinion:
- [By Lisa Levin]
Non-cyclical consumer goods & services sector was the top gainer in the US market on Wednesday. Top gainers in the sector included Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG), Companhia Paranaense de Energia (ADR) (NYSE: ELP), and NRG Energy Inc (NYSE: NRG).
- [By Lisa Levin]
In trading on Friday, utilities shares fell by 0.33 percent. Meanwhile, top losers in the sector included Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG), down 3 percent, and Companhia Paranaense de Energia (ADR) (NYSE: ELP), down 3 percent.
- [By Lisa Levin]
In trading on Monday, utilities shares fell 0.66 percent. Meanwhile, top losers in the sector included RGC Resources Inc. (NASDAQ: RGCO), down 5 percent, and Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG), down 5 percent.
stock market online: Insys Therapeutics, Inc.(INSY)
Advisors’ Opinion:
- [By William Patalon III]
Insys Therapeutics Inc. (NASDAQ: INSY) – our “War on Pain” biotech play – has given us a profit of more than 16% since we recommended the stock just two weeks ago.
- [By Peter Graham]
Small cap Insys Therapeutics (NASDAQ: INSY) is the seventh most shorted stock on the Nasdaq with short interest of 43.97% according to Highshortinterest.com. Insys Therapeutics is a small cap specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve patients quality of life. Using proprietary spray technology and capabilities to develop pharmaceutical cannabinoids,the Companyis developing a pipeline of products intending to address unmet medical needs and the clinical shortcomings of existing commercial products. INSYS currently markets SUBSYS庐 (fentanyl sublingual spray), CII, and SYNDROS庐 (dronabinol) oral solution, CII, a proprietary, orally administered liquid formulation of dronabinol.The Company aims to developmedications for potentially treating addiction to opioids, opioid overdose, epilepsy and other disease areas with a significant unmet need.
- [By Keith Speights]
Insys Therapeutics (NASDAQ:INSY) already won U.S. regulatory approval fordronabinol solution Syndros in treatingchemotherapy-induced nausea and vomiting (CINV) and anorexia in patients with AIDS. The company is preparing to launch Syndros soon.
- [By Keith Speights]
There are plenty of reasons for investors to like three marijuana stocks in particular — GW Pharmaceuticals (NASDAQ:GWPH), Insys Therapeutics (NASDAQ:INSY), and Aphria (NASDAQOTH:APHQF). In fact, there are at least 661 million reasons. That’s the amount of cash in U.S. dollars that the three companies have combined. Here’s why the cash stockpiles held by GW, Insys, and Apria are important.
stock market online: Abertis Infraestructuras S.A. (ABFOF)
Advisors’ Opinion:
- [By SEEKINGALPHA.COM]
Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)
stock market online: iShares Global Infrastructure (IGF)
Advisors’ Opinion:
- [By WWW.THESTREET.COM]
It also helps to find funds that can make any wait bearable and even profitable. Several ETFs stand out for their relatively low cost, modest risk and reasonable yields. They include the Guggenheim S&P High Income Infrastructure ETF (GHII) , iShares S&P Global Infrastructure Index Fund (IGF) and FlexShares STOXX Global Broad Infrastructure Index Fund (NFRA) .
- [By Wayne Duggan]
Investors who are looking to invest in the companies that will likely be playing a central role in America’s infrastructure investment may want to consider the iShares S&P Global Infrastructure Index (NYSE: IGF).
